US equities
|
NVDA
$236.89
▲+1.26%
SPCX
$167.40
▲+5.31%
MU
$1,065.24
▼-0.90%
TSLA
$375.96
▲+1.45%
MSFT
$526.58
▲+1.75%
INTC
$116.84
▼-2.08%
SNDK
$1,722.46
▲+0.14%
META
$744.25
▲+2.22%
NVDA
$236.89
▲+1.26%
SPCX
$167.40
▲+5.31%
MU
$1,065.24
▼-0.90%
TSLA
$375.96
▲+1.45%
MSFT
$526.58
▲+1.75%
INTC
$116.84
▼-2.08%
SNDK
$1,722.46
▲+0.14%
META
$744.25
▲+2.22%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Prenetics Global Limited - Class A Ordinary Share
(NQ:
PRE
)
20.14
-0.03 (-0.15%)
Delayed Quote
Updated: 10:29 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prenetics Global Limited - Class A Ordinary Share
< Previous
1
2
3
4
5
6
7
Next >
Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
August 26, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics (PRE) Q2 2026 Earnings Call Transcript
↗
August 25, 2026
IM8 brand hits $251M annualized run rate as adjusted free cash flow turns positive.
Via
The Motley Fool
Topics
Earnings
Prenetics’ IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
August 20, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Global Q2 Earnings Call Highlights
↗
August 18, 2026
Prenetics Global (NASDAQ:PRE) reported second-quarter revenue of $46.5 million, up 29% sequentially and about 3.9 times from a year earlier, as its IM8 supplement business continued to add subscribers...
Via
MarketBeat
Topics
Earnings
Prenetics Global Ltd. (NASDAQ:PRE) Reports Q4 Revenue Beat and Narrower Loss on IM8 Strength
↗
February 18, 2026
Via
Chartmill
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
August 18, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics, Parent of IM8, Appoints II Ranked, Caroline Levy, Veteran Wall Street Consumer Analyst as Independent Director
August 17, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation
August 07, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
July 14, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue
June 10, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion
June 04, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
May 20, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics (PRE) Q1 2026 Earnings Call Transcript
↗
May 19, 2026
Prenetics (PRE) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Prenetics Global Q1 Earnings Call Highlights
↗
May 14, 2026
Prenetics Global (NASDAQ:PRE) said its first-quarter results reflected the company’s shift away from diagnostics and genome testing toward a subscription-driven consumer health model anchored by its...
Via
MarketBeat
Topics
Earnings
Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8
May 14, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M
May 14, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call
May 08, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
May 07, 2026
IM8 products, including Daily Ultimate Essentials, Daily Ultimate Longevity, and The Beckham Stack, to be integrated into Inter Miami’s training facility and made available to all players
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One
April 14, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership
April 02, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
March 24, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics to Participate in the 38th Annual ROTH Conference
March 18, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
The market is filled with gapping stocks in Friday's session.
↗
March 06, 2026
Via
Chartmill
Prenetics Authorizes $40 Million Share Repurchase Program
March 06, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million
March 03, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours
February 23, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
February 18, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
February 18, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors
February 17, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
February 17, 2026
From
Prenetics Global Limited
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
